The US Centers for Disease Control and Prevention and the US Food and Drug Administration have advised that the use of Johnson & Johnson’s Covid-19 vaccine be halted in the United States due to six confirmed cases of a “rare and serious” form of a blood clot.

READ ALSO : Actress Georgina Onuoha Slams FFK For Taking The COVID-19 Vaccine Months After Saying It Is Evil

According to a joint statement released on Tuesday by Anne Schuchat, principal deputy director of the CDC, and Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, the six cases occurred among women aged 18 to 48, and symptoms appeared six to 13 days after vaccination.

The six cases were among the more than 6.8 million doses of the Johnson & Johnson vaccine that were given out in the US.

READ ALSO : BREAKING: President Muhammadu Buhari Returns To Nigeria

The CDC said in a statement that it would call a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to look into these cases further and determine their importance.

 

“As part of its investigation into these cases, the FDA will review the analysis. Out of an abundance of caution, we suggest a pause in the use of this vaccine until that phase is complete. Because of the unusual treatment needed for this form of a blood clot, this is necessary for the part to ensure that the health care provider group is aware of the potential for these adverse effects and can prepare for appropriate recognition and management,” according to the release.

“Control of this particular form of a blood clot is distinct from treatment that would normally be administered,” according to the FDA.

This development comes after the suspension of the Oxford AstraZeneca vaccine in several countries due to a similar problem.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.